Todd A. Becker - Mar 3, 2025 Form 4 Insider Report for Core Scientific, Inc./tx (CORZ)

Role
Director
Signature
/s/ Todd DuChene, as Attorney-in-Fact
Stock symbol
CORZ
Transactions as of
Mar 3, 2025
Transactions value $
-$1,595,675
Form type
4
Date filed
3/5/2025, 06:23 PM
Previous filing
Jan 28, 2025
Next filing
Mar 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORZ Common Stock Sale -$1.44M -134K -40.69% $10.75 196K Mar 3, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORZ Tranche 1 Warrants Sale -$59.9K -10.8K -100% $5.57 0 Mar 3, 2025 Common Stock 10.8K $6.81 Direct F2, F3
transaction CORZ Tranche 2 Warrants Sale -$42.4K -3.9K -43.48% $10.86 5.07K Mar 3, 2025 Common Stock 3.9K $0.01 Direct F4, F5
transaction CORZ Tranche 2 Warrants Sale -$50.2K -5.07K -100% $9.89 0 Mar 4, 2025 Common Stock 5.07K $0.01 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F2 Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
F3 The price reported is a weighted average price. These Tranche 1 Warrants were sold in multiple transactions at prices ranging from $5.56 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 1 Warrants sold at each separate price within such range.
F4 Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.
F5 The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $10.75 to $10.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.
F6 The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $9.7867 to $9.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.